Young Whang, MD, PhD
ywhang.bsky.social
Young Whang, MD, PhD
@ywhang.bsky.social
Genitourinary medical oncologist
Press release of the trial of Pluvicto in metastatic hormone-sensitive prostate cancer (PSMAddition) meeting the primary endpoint.
www.novartis.com/news/media-r...
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
www.novartis.com
June 2, 2025 at 2:30 PM
The story behind the NIH indirect cap.
www.msn.com/en-us/news/p...
MSN
www.msn.com
February 20, 2025 at 2:50 PM
Reposted by Young Whang, MD, PhD
Excellent discussion on the current realities of using GLP-1 RAs in complex cases and in underserved communities in this Medscape Masters Series. Honored to participate as a guest with Drs. Jamie Almandoz, Ambarish Pandey & Tamaan K. Osbourne - Roberts www.medscape.com/viewarticle/...
GLP-1 for Complex Cases: Breakthrough Therapies in Care
Unlock the potential of GLP-1 therapies! Join experts to explore cutting-edge strategies for managing cardiovascular & endocrine cases. Enhance outcomes for complex patients with actionable insights.
www.medscape.com
January 31, 2025 at 4:13 PM
Unless this is reversed quickly, I'm concerned for the long term damage to biomedical research in the US.

www.nature.com/articles/d41...
‘Never seen anything like this’: Trump’s team halts NIH meetings and travel
In an unprecedented move, research-grant reviews have been suspended indefinitely at the world’s largest public funder of biomedical research.
www.nature.com
January 25, 2025 at 6:54 PM